SCHEMBL5368564

SCHEMBL5368564

Cc1c(Br)ccc2c1C(=Cc1ccc(Cl)s1)C(=O)N2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
ERBB2 P04626 1/20 0.46
ALPL P05186 1/20 0.41
HSP90AA1 P07900 1/20 0.41
ALPI P09923 1/20 0.41
ALPG P10696 1/20 0.41
G6PD P11413 1/20 0.41
POLB P06746 2/20 0.39
RAF1 P04049 1/20 0.39
EGFR P00533 2/20 0.38
LRRK2 Q5S007 2/20 0.35
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
MDM2 Q00987 1/20 0.35
KDR P35968 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5357849 0.88 MEN1 (0.55) MEN1KMT2AERBB2ALPLHSP90AA1
SCHEMBL5361220 0.88 ERBB2 (0.47) MEN1KMT2AERBB2ALPLHSP90AA1
SCHEMBL5363130 0.84 ERBB2 (0.67) MEN1KMT2AERBB2ALPLHSP90AA1
SCHEMBL5370157 0.84 EGFR (0.58) MEN1KMT2AERBB2ALPLHSP90AA1
SCHEMBL7130491 0.82 KMT2A (0.48) MEN1KMT2AERBB2ALPLHSP90AA1
SCHEMBL5376938 0.81 ERBB2 (0.43) MEN1KMT2AERBB2ALPLHSP90AA1
SCHEMBL7138976 0.80 POLB (0.41) ERBB2POLBRAF1KDRRET
SCHEMBL7134022 0.79 LRRK2 (0.48) ERBB2LRRK2PSEN1PSEN2APH1B
SCHEMBL7131400 0.77 MEN1 (0.42) MEN1KMT2AMDM2KDRRET
SCHEMBL7134020 0.76 LRRK2 (0.49) ERBB2RAF1LRRK2PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK MEN1 3855/4885KMT2A 4060/4885ERBB2 19/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.